[PDF][PDF] Nationwide survey on complementary and alternative medicine in cancer patients in Japan
…, N Amano, K Eguchi, M Narabayashi… - Journal of clinical …, 2005 - researchgate.net
Purpose To determine the prevalence of use of complementary and alternative medicine
(CAM) by patients with cancer in Japan, and to compare the characteristics of CAM users …
(CAM) by patients with cancer in Japan, and to compare the characteristics of CAM users …
Dose–volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer
…, K Shibuya, M Nakamura, M Narabayashi… - International Journal of …, 2012 - Elsevier
PURPOSE: To identify dose–volume factors associated with radiation pneumonitis (RP) after
stereotactic body radiation therapy (SBRT) for lung cancer. METHODS AND MATERIALS: …
stereotactic body radiation therapy (SBRT) for lung cancer. METHODS AND MATERIALS: …
Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors
H Okamura, T Watanabe, M Narabayashi… - Breast cancer research …, 2000 - Springer
Objectives: To investigate the prevalence of, and risk factors for psychological distress
following first recurrences of breast cancer. Patients and methods: The sample was drawn …
following first recurrences of breast cancer. Patients and methods: The sample was drawn …
[PDF][PDF] Construction and validation of a practical prognostic index for patients with metastatic breast cancer.
…, M Ando, H Fukuda, Y Takue, M Narabayashi… - Journal of clinical …, 1998 - Citeseer
Purpose: To identify the readily available prognostic factors most helpful in predicting
survival and to construct and validate a prognostic index for metastatic breast cancer (MBC) …
survival and to construct and validate a prognostic index for metastatic breast cancer (MBC) …
Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer
…, T Yokota, M Arai, Y Tada, M Narabayashi… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Opioid-induced constipation (OIC) is a frequent and debilitating adverse effect (AE)
of opioids—common analgesics for cancer pain. We investigated the efficacy and safety of a …
of opioids—common analgesics for cancer pain. We investigated the efficacy and safety of a …
Prognostic factors in stereotactic body radiotherapy for non–small-cell lung cancer
…, Y Norihisa, T Mizowaki, M Narabayashi… - International Journal of …, 2011 - Elsevier
PURPOSE: To investigate the factors that influence clinical outcomes after stereotactic body
radiotherapy (SBRT) for non–small-cell lung cancer (NSCLC). METHODS AND MATERIALS…
radiotherapy (SBRT) for non–small-cell lung cancer (NSCLC). METHODS AND MATERIALS…
Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer
…, F Nagashima, W Ichikawa, M Narabayashi… - Cancer chemotherapy …, 2010 - Springer
Purpose To investigate the effects of genetic polymorphisms on morphine-induced adverse
events in cancer patients. Methods We examined the relation of morphine-related adverse …
events in cancer patients. Methods We examined the relation of morphine-related adverse …
Toxicity grading criteria of the Japan clinical oncology group
…, T Watanabe, T Tamura, K Takeyama, M Narabayashi… - 1993 - arch.neicon.ru
… ; Fukutomi, Takashi; Kondo, Haruhiko; Shimoyama, Masanori; Suemasu, Keiichi; Tobinai
Kensei; Departments of Medical Oncology, National Cancer Center Hospital; Kohno Akio; …
Kensei; Departments of Medical Oncology, National Cancer Center Hospital; Kohno Akio; …
Phase IIb, randomized, double-blind, placebo-controlled study of naldemedine for the treatment of opioid-induced constipation in patients with cancer
…, T Yokota, Y Suzuki, M Narabayashi… - Journal of Clinical …, 2017 - ascopubs.org
Purpose This randomized, double-blind, multicenter study aimed to determine the dose of
naldemedine, a peripherally-acting μ-opioid receptor antagonist, for future trials by comparing …
naldemedine, a peripherally-acting μ-opioid receptor antagonist, for future trials by comparing …
Incidence and risk factors of symptomatic radiation pneumonitis in non–small-cell lung cancer patients treated with concurrent chemoradiotherapy and consolidation …
…, T Kishi, T Atsuta, T Sakamoto, M Narabayashi… - Clinical Lung Cancer, 2021 - Elsevier
Introduction Data on the risk factors for symptomatic radiation pneumonitis (RP) in non–small-cell
lung cancer (NSCLC) patients treated with concurrent chemoradiotherapy (CCRT) and …
lung cancer (NSCLC) patients treated with concurrent chemoradiotherapy (CCRT) and …